Incyte (INCY) Change in Account Payables (2010 - 2026)
Incyte posted quarterly Change in Account Payables of $23.4 million for Q1 2026, up 1186.1% year-on-year from $1.8 million in Q1 2025, and down 28.89% on a QoQ basis from $33.0 million in Q4 2025.
Incyte (INCY) has 17 years of Change in Account Payables data on file, last reported at $23.4 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 1186.1% year-over-year to $23.4 million; the trailing twelve-month figure through Mar 2026 stood at $32.2 million (up 2.57% YoY), and the FY2025 full-year result was $6.6 million, down 92.56% from the prior year.
- Change in Account Payables for Q1 2026 stood at $23.4 million, down from $33.0 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $114.4 million in Q4 2022 and bottomed at -$221.9 million in Q1 2023.
- The 5-year median for Change in Account Payables is $19.0 million (2024), against an average of $3.3 million.
- The widest annual swing landed in 2023, when Change in Account Payables tumbled 1034.35%; it then soared 1186.1% in 2026.
- A 5-year view of Change in Account Payables shows it stood at $114.4 million in 2022, then tumbled by 126.06% to -$29.8 million in 2023, then jumped by 163.9% to $19.0 million in 2024, then jumped by 73.1% to $33.0 million in 2025, then retreated by 28.89% to $23.4 million in 2026.
- The last three Change in Account Payables figures came in at $23.4 million (Q1 2026), $33.0 million (Q4 2025), and -$44.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 23.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.45 Mn |
| Mar 31, 2026 | 23.45 Mn |
| Dec 31, 2025 | 32.98 Mn |
| Dec 31, 2025 | 32.98 Mn |
| Sep 30, 2025 | -44.17 Mn |
| Sep 30, 2025 | -44.17 Mn |
| Jun 30, 2025 | 19.91 Mn |
| Jun 30, 2025 | 19.91 Mn |
| Mar 31, 2025 | -2.16 Mn |
| Mar 31, 2025 | -2.16 Mn |
| Dec 31, 2024 | 19.05 Mn |
| Dec 31, 2024 | 19.05 Mn |
| Sep 30, 2024 | 30.54 Mn |
| Sep 30, 2024 | 30.54 Mn |
| Jun 30, 2024 | -16.06 Mn |
| Jun 30, 2024 | -16.06 Mn |
| Mar 31, 2024 | 54.64 Mn |
| Mar 31, 2024 | 54.64 Mn |
| Dec 31, 2023 | -29.81 Mn |
| Dec 31, 2023 | -29.81 Mn |
| Sep 30, 2023 | -16.13 Mn |
| Sep 30, 2023 | -16.13 Mn |
| Jun 30, 2023 | 99.91 Mn |
| Jun 30, 2023 | 99.91 Mn |
| Mar 31, 2023 | -221.91 Mn |
| Mar 31, 2023 | -221.91 Mn |
| Dec 31, 2022 | 114.37 Mn |
| Dec 31, 2022 | 114.37 Mn |
| Sep 30, 2022 | -31.60 Mn |
| Sep 30, 2022 | -31.60 Mn |
| Jun 30, 2022 | 42.22 Mn |
| Jun 30, 2022 | 42.22 Mn |
| Mar 31, 2022 | -19.56 Mn |
| Mar 31, 2022 | -19.56 Mn |
| Dec 31, 2021 | 57.60 Mn |
| Dec 31, 2021 | 57.60 Mn |
| Sep 30, 2021 | -7.59 Mn |
| Sep 30, 2021 | -7.59 Mn |
| Jun 30, 2021 | 37.04 Mn |
| Jun 30, 2021 | 37.04 Mn |
| Mar 31, 2021 | -13.71 Mn |
| Mar 31, 2021 | -13.71 Mn |
| Dec 31, 2020 | -23.75 Mn |
| Dec 31, 2020 | -23.75 Mn |
| Sep 30, 2020 | 31.60 Mn |
| Sep 30, 2020 | 31.60 Mn |
| Jun 30, 2020 | 29.97 Mn |
| Jun 30, 2020 | 29.97 Mn |
| Mar 31, 2020 | -22.71 Mn |
| Mar 31, 2020 | -22.71 Mn |
| Dec 31, 2019 | -11.73 Mn |
| Dec 31, 2019 | -11.73 Mn |
| Sep 30, 2019 | 23.79 Mn |
| Sep 30, 2019 | 23.79 Mn |
| Jun 30, 2019 | 1.22 Mn |
| Jun 30, 2019 | 1.22 Mn |
| Mar 31, 2019 | -33.46 Mn |
| Mar 31, 2019 | -33.46 Mn |
| Dec 31, 2018 | 8.35 Mn |
| Dec 31, 2018 | 8.35 Mn |
| Sep 30, 2018 | 19.92 Mn |
| Sep 30, 2018 | 19.92 Mn |
| Jun 30, 2018 | 1.44 Mn |
| Jun 30, 2018 | 1.44 Mn |
| Mar 31, 2018 | 6.44 Mn |
| Mar 31, 2018 | 6.44 Mn |
| Dec 31, 2017 | -2.26 Mn |
| Dec 31, 2017 | -2.26 Mn |
| Sep 30, 2017 | 840,000.00 |
| Sep 30, 2017 | 840,000.00 |
| Jun 30, 2017 | -17.23 Mn |
| Jun 30, 2017 | -17.23 Mn |
| Mar 31, 2017 | 10.73 Mn |
| Mar 31, 2017 | 10.73 Mn |
| Dec 31, 2016 | 18.08 Mn |
| Dec 31, 2016 | 18.08 Mn |
| Sep 30, 2016 | 16.80 Mn |
| Sep 30, 2016 | 16.80 Mn |
| Jun 30, 2016 | 7.07 Mn |
| Jun 30, 2016 | 7.07 Mn |
| Mar 31, 2016 | 1.81 Mn |
| Mar 31, 2016 | 1.81 Mn |
| Dec 31, 2015 | 2.72 Mn |
| Dec 31, 2015 | 2.72 Mn |
| Sep 30, 2015 | -1.80 Mn |
| Sep 30, 2015 | -1.80 Mn |
| Jun 30, 2015 | 2.58 Mn |
| Jun 30, 2015 | 2.58 Mn |
| Mar 31, 2015 | 2.12 Mn |
| Mar 31, 2015 | 2.12 Mn |
| Dec 31, 2014 | -2.14 Mn |
| Dec 31, 2014 | -2.14 Mn |
| Sep 30, 2014 | -646,000.00 |
| Sep 30, 2014 | -646,000.00 |
| Jun 30, 2014 | 9.30 Mn |
| Jun 30, 2014 | 9.30 Mn |
| Mar 31, 2014 | -1.15 Mn |
| Mar 31, 2014 | -1.15 Mn |
| Dec 31, 2013 | 890,000.00 |
| Dec 31, 2013 | 890,000.00 |
| Sep 30, 2013 | 4.74 Mn |
| Sep 30, 2013 | 4.74 Mn |
| Jun 30, 2013 | -2.04 Mn |
| Jun 30, 2013 | -2.04 Mn |
| Mar 31, 2013 | 1.55 Mn |
| Mar 31, 2013 | 1.55 Mn |
| Dec 31, 2012 | 1.20 Mn |
| Dec 31, 2012 | 1.20 Mn |
| Sep 30, 2012 | 1.66 Mn |
| Sep 30, 2012 | 1.66 Mn |
| Jun 30, 2012 | -2.07 Mn |
| Jun 30, 2012 | -2.07 Mn |
| Mar 31, 2012 | -1.77 Mn |
| Mar 31, 2012 | -1.77 Mn |
| Dec 31, 2011 | 3.90 Mn |
| Dec 31, 2011 | 3.90 Mn |
| Sep 30, 2011 | 2.25 Mn |
| Sep 30, 2011 | 2.25 Mn |
| Jun 30, 2011 | 997,000.00 |
| Jun 30, 2011 | 997,000.00 |
| Mar 31, 2011 | -2.98 Mn |
| Mar 31, 2011 | -2.98 Mn |
| Dec 31, 2010 | 3.02 Mn |
| Dec 31, 2010 | 3.02 Mn |
| Sep 30, 2010 | -1.41 Mn |
| Sep 30, 2010 | -1.41 Mn |
| Jun 30, 2010 | -4.15 Mn |
| Jun 30, 2010 | -4.15 Mn |
| Mar 31, 2010 | -7.66 Mn |
| Mar 31, 2010 | -7.66 Mn |